These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 756881)

  • 21. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
    Speckart P; Zia P; Zipser R; Horton R
    J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of beta-adrenergic blockade on patterns of urinary sodium excretion, blood pressure and plasma renin activity in patients with essential and renovascular hypertension.
    Salvetti A; Sassano P; Poli L; Arzilli F; Pedrinelli R
    Eur J Clin Invest; 1977 Oct; 7(5):331-6. PubMed ID: 411663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].
    Grüninger U; Akert R; Hunkeler H; Wegmüller E; Weidmann P; Hodler J
    Klin Wochenschr; 1979 Jul; 57(14):731-9. PubMed ID: 470335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the mechanism of action of prostaglandin synthesis inhibitors on renin and aldosterone secretion and sodium excretion.
    Papanicolaou N; Papadakis G; Papanicolaou P; Theodorakopoulos P; Paris M; Dontas A; Paris M; Bariety J; Milliez P
    Prostaglandins Med; 1981 Aug; 7(2):163-81. PubMed ID: 6792644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The renin-angiotensin-aldosterone system in the diagnosis of renovascular arterial hypertension].
    Sánchez Torres G; Posadas C; Millán AJ; Gutiérrez Fuster E; Serrano Mass P; Rangel J; Cuéllar A
    Arch Inst Cardiol Mex; 1976; 46(2):198-212. PubMed ID: 938159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy.
    Lammintausta R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):581-4. PubMed ID: 365799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
    Thomas GW; Ledingham JG; Beilin LJ; Yeates KM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renin aldosterone profile in essential hypertension during pregnancy and after delivery].
    Niegowska J; Sitkiewicz D
    Pol Arch Med Wewn; 2004 May; 111(5):547-56. PubMed ID: 15508805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
    Rabinowe SL; Taylor T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of penbutolol on circadian blood pressure, and renin, aldosterone and cortisol levels in patients with essential hypertension.
    degli Uberti EC; Portaluppi F; Margutti A; Trasforini G; Bianconi M; Teodori V; Rossi R; Pansini R
    Acta Cardiol; 1988; 43(1):5-20. PubMed ID: 3287810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are plasma renin activity and aldosterone levels useful as a screening test to differentiate between unilateral and bilateral renal artery stenosis in hypertensive patients?
    Kotliar C; Inserra F; Forcada P; Cavanagh E; Obregon S; Navari C; Castellaro C; Sánchez R
    J Hypertens; 2010 Mar; 28(3):594-601. PubMed ID: 20104188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low plasma renin activity and high aldosterone/renin ratio are associated with untreated isolated systolic hypertension.
    Durukan M; Guray U; Aksu T; Guray Y; Demirkan B; Korkmaz S
    Blood Press; 2012 Oct; 21(5):320-5. PubMed ID: 22587638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
    Allikmets K; Parik T; Teesalu R
    Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading.
    Williams GH; Cain JP; Dluhy RG; Underwood RH
    J Clin Invest; 1972 Jul; 51(7):1731-42. PubMed ID: 4338121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of prostaglandin A1 on renin and aldosterone in man.
    Golub MS; Speckart PF; Zia PK; Horton R
    Circ Res; 1976 Oct; 39(4):574-9. PubMed ID: 963841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of prostaglandins in the antihypertensive effect of the converting enzyme inhibitor, enalapril].
    Espinoza F; Gallego A; Ruiz A; Pérez-Grovas H; Garza Flores J; Morato T; Herrera-Acosta J
    Rev Invest Clin; 1989; 41(4):351-60. PubMed ID: 2561022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.